QYUNS-B (02509) spent 1.835 million Hong Kong dollars to repurchase 84,000 shares on January 20th.
Chun Sing Biology-B (02509) announced that it repurchased 84,000 shares at a cost of HK$1.835 million on January 20, 2026.
QYUNS-B (02509) announced on January 20, 2026 that it would spend 1.835 million Hong Kong dollars to repurchase 84,000 shares.
Related Articles

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families






